Loading company…
Post Translational Medicines develops drug discovery technology focused on the Dark Proteome.
Founded in 2025 in Singapore, Post Translational Medicines develops drug discovery technology through its Surveyor™ Platform, which analyzes proteoforms and previously inaccessible therapeutic targets. The company serves pharmaceutical firms and research institutions investigating difficult diseases. In July 2025, it raised Seed funding from SOSV to develop the platform and products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in